{
    "clinical_study": {
        "@rank": "65517", 
        "arm_group": {
            "arm_group_label": "Liposonix with pre-treatment analgesia", 
            "arm_group_type": "Experimental", 
            "description": "Liposonix System (Model 2) treatment of subcutaneous adipose tissue with pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)"
        }, 
        "brief_summary": {
            "textblock": "The objectives of this study are to evaluate the safety and effectiveness of procedural\n      analgesia for improvements in tolerability of treatment with the Liposonix System."
        }, 
        "brief_title": "Evaluation of Procedural Analgesia for Liposonix Treatment", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Liposonix System (Model 2) treatment of subcutaneous adipose tissue with pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)\nLiposonix System (Model 2): Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).\nPre-treatment analgesia: Pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)", 
                        "title": "Liposonix With Pre-treatment Analgesia"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "11"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "11.2", 
                                            "@value": "35.9"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "9"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "11"
                                        }
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "Intent-to-Treat"
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Investigator shall notify Sponsor of the intent to publish or present independent Study Data, and agrees not to publish or publicly present and/or discuss such data, Investigator\u2019s current findings and/or the results of the Study independently without the express written consent of Sponsor, which consent may be withheld.  Prior to submission for publication or presentation, all draft manuscripts must be submitted, reviewed and approved by Sponsor for confidential material."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Following treatment, the subject was asked to evaluate the pain level for the overall treatment using the 0-10 Visual Analog Scale (0 represents no pain and 10 represents worst imaginable pain)", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Liposonix System (Model 2) treatment of subcutaneous adipose tissue with pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)\nLiposonix System (Model 2): Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).\nPre-treatment analgesia: Pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)", 
                                "title": "Liposonix With Pre-treatment Analgesia"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "11"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "2.2", 
                                                    "@value": "6.3"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Following treatment, the subject was asked to evaluate the pain level for the overall treatment using the 0-10 Visual Analog Scale (0 represents no pain and 10 represents worst imaginable pain)", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Pain Score for Overall Treatment", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Intent to Treat", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline", 
                        "title": "Pain Score for Overall Treatment", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Adverse events will be assessed and documented throughout the study", 
                        "safety_issue": "Yes", 
                        "time_frame": "Baseline, 1 day, 1 week", 
                        "title": "Safety Assessment", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "During the 1-day follow-up phone call, subjects were asked to rate the pain they were currently experiencing from the Liposonix treatment using a 0-10 pain scale (0 represents no pain and 10 represents worst pain imaginable).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Liposonix System (Model 2) treatment of subcutaneous adipose tissue with pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)\nLiposonix System (Model 2): Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).\nPre-treatment analgesia: Pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)", 
                                "title": "Liposonix With Pre-treatment Analgesia"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "11"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "2.6", 
                                                    "@value": "2.1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "During the 1-day follow-up phone call, subjects were asked to rate the pain they were currently experiencing from the Liposonix treatment using a 0-10 pain scale (0 represents no pain and 10 represents worst pain imaginable).", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Pain Scores Reported at 1-day Post-Treatment", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Intent-to-Treat", 
                        "safety_issue": "No", 
                        "time_frame": "1 day", 
                        "title": "Pain Scores Reported at 1-day Post-Treatment", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Liposonix System (Model 2) treatment of subcutaneous adipose tissue with pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)\nLiposonix System (Model 2): Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).\nPre-treatment analgesia: Pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)", 
                        "title": "Liposonix With Pre-treatment Analgesia"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "11", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "11", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "aloncaric@solta.com", 
                "name_or_title": "Director of Clinical Programs", 
                "organization": "Solta Medical", 
                "phone": "510-259-5284"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Liposonix System (Model 2) treatment of subcutaneous adipose tissue with pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)\nLiposonix System (Model 2): Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).\nPre-treatment analgesia: Pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)", 
                        "title": "Liposonix With Pre-treatment Analgesia"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "11", 
                                            "@subjects_at_risk": "11"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "11", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Pain during treatment"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Nausea/Vomiting"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "2", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Dizziness/Feeling Faint"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Tiredness"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "2", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Headache"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Feeling cold"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Pain with movement"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Sense of pressure at treatment site"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Flu-like symptoms"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "10", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "10", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Ecchymosis"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "11", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Erythema"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "5", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Tenderness"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "5", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Soreness"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "5", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Tingling/Altered Sensation"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Edema"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "2", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Warm sensation on treatment area"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "2", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Surface sensitivity/soreness at treatment site"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Itching"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Bruising at attempted IV site"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "11"
                                            }, 
                                            "sub_title": "Burning sensation to touch"
                                        }
                                    ]
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "frequency_threshold": "0"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "11"
                                        }, 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "11"
                                        }, 
                                        "description": "Patient admitted to hospital following car accident for lower back pain.  Unrelated to treatment", 
                                        "sub_title": "Car Accident"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment"
                }, 
                "time_frame": "Adverse event data were collected from day 0 through study follow-up (1 week post-treatment)"
            }
        }, 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Body Contouring", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is an adult female or male, 18 to 65 years of age.\n\n          -  Subject must weigh more than 120 pounds.\n\n          -  Subject must have a Body Mass Index of \u2264 30 kg/m2.\n\n          -  Subject must have thickness of skin + subcutaneous adipose tissue in the anticipated\n             treatment area of \u2265 2.3 cm.\n\n          -  Subject must be able to read, write, speak, and understand English.\n\n        Exclusion Criteria:\n\n          -  Female subject who is pregnant, is suspected to be pregnant, or is lactating\n\n          -  Subjects diagnosed with coagulation disorders or are receiving anticoagulant therapy\n             or medications or dietary supplements which impede coagulation or platelet\n             aggregation\n\n          -  Subject has diabetes or cardiovascular disease\n\n          -  Subject has had any aesthetic procedure to the region to be treated within past 6\n             months\n\n          -  Subject has systemic skin disease or skin disease in the area to be treated\n\n          -  Subject has any abnormality of the skin or soft tissues of the abdominal wall in the\n             area to be treated\n\n          -  Subject has had previous open or laparoscopic surgery in the anticipated treatment\n             area\n\n          -  Subjects is on prescription or over the counter weight reduction medication or\n             programs, or had weight reduction procedures\n\n          -  Subject has skin or superficial tissue that does not lie flat on its own when the\n             subject is in the supine position\n\n          -  Subjects undergoing chronic steroid or immunosuppressive therapy\n\n          -  Subjects who have cardiac pacemakers or any implantable electrical device\n\n          -  Subjects who have metal implants of any type in the area to be treated\n\n          -  History of cancer\n\n          -  Subjects who have sensory loss or dysesthesia in the area to be treated\n\n          -  Subjects taking chronic benzodiazepines or opiates\n\n          -  Subjects with a history of severe nausea/vomiting with opioid analgesics\n\n          -  Subjects with sleep apnea\n\n          -  Subjects with known allergies or sensitivities to study drugs\n\n          -  Subjects with liver disease\n\n          -  Subjects with renal failure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "11", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 11, 2013", 
        "firstreceived_results_date": "March 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01993238", 
            "org_study_id": "13-140-LP-H"
        }, 
        "intervention": [
            {
                "arm_group_label": "Liposonix with pre-treatment analgesia", 
                "description": "Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).", 
                "intervention_name": "Liposonix System (Model 2)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Liposonix with pre-treatment analgesia", 
                "description": "Pre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)", 
                "intervention_name": "Pre-treatment analgesia", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 25, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hayward", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94545"
                }, 
                "name": "Solta Medical Aesthetic Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Evaluation of Procedural Analgesia for Out-Patient Liposonix Treatment", 
        "overall_official": [
            {
                "last_name": "Ronald Wheeland, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "last_name": "Reid Rubsamen, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Following treatment, the subject was asked to evaluate the pain level for the overall treatment using the 0-10 Visual Analog Scale (0 represents no pain and 10 represents worst imaginable pain)", 
            "measure": "Pain Score for Overall Treatment", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01993238"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Adverse events will be assessed and documented throughout the study", 
                "measure": "Safety Assessment", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, 1 day, 1 week"
            }, 
            {
                "description": "During the 1-day follow-up phone call, subjects were asked to rate the pain they were currently experiencing from the Liposonix treatment using a 0-10 pain scale (0 represents no pain and 10 represents worst pain imaginable).", 
                "measure": "Pain Scores Reported at 1-day Post-Treatment", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }
        ], 
        "source": "Solta Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Solta Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}